The Medicines (MDCO)
39.81
-0.64 -1.58%
NASDAQ
Sep 26, 20:00
Delayed 2m
USD
View All Key Stats
MDCO Key Stats
| Income Statement | |
| Revenue (TTM) | 197.06M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.45 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -221.20M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 72.17% |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 2.809B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 14.03 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 3.389 |
| Other | |
| Beta | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.8009 |
| Free Cash Flow (Quarterly) | -103.78M |
| Return on Equity (TTM) | -26.97% |
View All MDCO News
MDCO News
-
WireHeadlineTime (ET)
-
Yahoo09/22 09:29
-
Yahoo09/22 09:18
-
SA Breaking News09/21 07:58
-
MT Newswires09/21 07:48
-
Reuters09/21 07:30
-
Yahoo09/21 07:30
-
Business Wire09/21 07:30
-
Yahoo09/14 10:20
-
Yahoo09/13 11:41
-
Yahoo09/12 09:16
View All Events
MDCO Events
| Date | Type | Description |
|---|---|---|
| 07/27/2016 08:30 EDT | Misc | The Medicines Co Second Quarter Earnings Conference Call in 2016 |
| 07/27/2016 | Earnings | The Medicines Co Second Quarter Earnings in 2016 Release |
| 06/27/2016 08:30 EDT | Misc | Tesco PLC Annual General Meeting in 2016 |
| 05/26/2016 | Misc | The Medicines Co Annual General Meeting in 2015 |
| 05/09/2016 08:30 EDT | Misc | The Medicines Co First Quarter Earnings Conference Call in 2016 |
| 05/09/2016 | Earnings | The Medicines Co First Quarter Earnings in 2016 Release |
| 02/17/2016 08:30 EST | Misc | The Medicines Co Fourth Quarter Earnings Conference Call in 2015 |
| 02/17/2016 | Earnings | The Medicines Co Fourth Quarter Earnings in 2015 Release |
| 11/03/2015 08:30 EDT | Misc | The Medicines Company Third Quarter Earnings Conference Call in 2015 |
| 11/03/2015 | Earnings | The Medicines Company Third Quarter Earnings in 2015 Release |
MDCO Fundamentals
Income Statement View Statement
MDCO Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.themedicinescompany.com
- Investor Relations URL: http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-irhome
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: July 27, 2016
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: The Medicines Co is a biopharmaceutical company. The Company markets Angiomax, Cleviprex injectable emulsion, Minocin for injection, Orbactiv, PreveLeakTM and Recothrom Thrombin topical. The Company also sells ready‑to‑use formulation of Argatroban.
MDCO Comparables
EditMDCO Excel Add-In Codes
- Name: =YCI("MDCO","name")
- Description: =YCI("MDCO","description")
- Sector: =YCI("MDCO","sector")
- Industry: =YCI("MDCO","industry")
- Est. Current Fiscal Year End: =YCI("MDCO","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MDCO Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MDCO Tweets Stocktwits
Advertisement